ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,264,000 | -51.7% | 23,657 | +2.0% | 0.33% | -52.3% |
| Q4 2015 | $2,619,000 | -0.9% | 23,182 | +3.2% | 0.70% | -0.4% |
| Q3 2015 | $2,644,000 | -71.0% | 22,459 | -80.9% | 0.70% | -66.7% |
| Q2 2015 | $9,104,000 | +33.5% | 117,575 | -0.3% | 2.10% | +35.4% |
| Q1 2015 | $6,819,000 | +7.6% | 117,875 | -40.0% | 1.55% | +17.3% |
| Q4 2014 | $6,339,000 | -44.3% | 196,557 | -57.8% | 1.32% | -35.4% |
| Q3 2014 | $11,385,000 | +18.2% | 465,252 | -14.3% | 2.04% | +31.4% |
| Q2 2014 | $9,630,000 | -8.6% | 543,162 | +3.2% | 1.56% | -9.8% |
| Q1 2014 | $10,534,000 | +21.1% | 526,459 | +1.5% | 1.72% | +20.2% |
| Q4 2013 | $8,700,000 | +57.5% | 518,466 | -0.3% | 1.44% | +35.5% |
| Q3 2013 | $5,523,000 | +91.9% | 520,091 | +1.0% | 1.06% | +67.3% |
| Q2 2013 | $2,878,000 | – | 514,891 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |